Investor Ideas adds New CSE-Listed Cannabis Stocks (CSE: $IMCC.C) (CSE: $ABCS.C) (CSE: $LOAN.C) (CSE: $RAMM.C) (CSE: $CNTR.C)
Point Roberts, WA and Delta, BC - November 8, 2019 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks announces this week's additions to its cannabis /hemp stock directory for investors following the sector.
New cannabis companies are CSE (Canadian stock exchange) listed and are involved the in CBD sector with IM Cannabis Corp (CSE:IMCC) involved in the medical cannabis sector in Israel and CENTR Brands Corp. (CSE: CNTR) crossing over into the beverage sector, respectively.
This week's new Marijuana/Cannabis Stocks Added to the Investor cannabis stock directory:
IM Cannabis Corp (CSE:IMCC) is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMCC intends to leverage IMCC's brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece.
Abacus Health Products Inc. (CSE: ABCS) is engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from the Cannabis sativa L plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus' formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: CBD CLINIC™, marketed to the professional practitioner market, and CBDMEDIC™, marketed to the consumer market. Abacus' products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.
Redfund Capital Corp. (CSE: LOAN) intends to provide debt and equity funding in the mid-to-late stages of a target company's development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.
RAMM Pharma Corp (CSE:RAMM) through its wholly-owned operating subsidiaries, is engaged in the pharmaceutical and medical product business, and is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. With RAMM's large scale cultivation facility, the combined operations are expected to provide for complete vertical integration. Further to its industry leading activities in the cannabis sector, RAMM operates a pharmaceutical, cosmetic and nutraceutical product development and medical services business which has been servicing the local market for 30
CENTR Brands Corp. (CSE: CNTR) (FSE: 303) develops and markets non-alcoholic beverages for the North American market. The Company's initial focus is on the creation and launch of a global brand for the cannabidiol (CBD) infused beverage market. The Company's first product, named CENTR, is a sparkling, low-calorie, CBD beverage.
For investors following the sector Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks. Visit directory.
Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format. The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review.
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns : Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Learn more about our news, PR and social media services at Investorideas.com
Follow us on cannabis social media
Download our Mobile App for iPhone and Android
To sponsor a daily podcast for the month or to be an expert guest please contact us!